Smart Implantable Pumps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The smart implantable pumps market is segmented by Type (Perfusion pumps and Micro pumps), Application (Pain, Spasticity, Cardiovascular and Others), End User (Hospitals, Ambulatory Surgical Centers and Others) and Geography.

Market Snapshot

 micro pump market share
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %
intelligent pumps market size

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Smart Implantable Pumps market is expected to augment with an anticipated CAGR of 7.5%, during the forecast period (2020-2025).

The major factors accounting for the growth of the Smart Implantable Pumps market are high prevalence and incidence of chronic diseases such as spasticity and chronic pain, presence of a large geriatric population that is more prone to chronic diseases, growing health consciousness, rising healthcare expenditures and favorable reimbursement policies. According to WHO the burden of chronic diseases worldwide will reach 57% by the end of 2020 and is expected to increase further due to continuous population growth and a higher incidence rate of chronic diseases. Hence, the high incidence and prevalence of chronic diseases drive the growth of the Smart Implantable Pumps market during the forecast period. However, the stringent regulatory framework and high standards set by the market leaders are expected to hamper the growth of the market. For example, according to the FDA’s report, one of the market player Medtronic recalled SynchroMed II Implantable Drug Infusion Pump owing to the potential presence of foreign particles inside the pump motor assembly.

Scope of the Report

Smart Implantable Pumps enable the monitoring of drug delivery rate exteriorly, which is beyond the abilities of conservative controlled release preparations. Implantable pumps consist of a reservoir placed subcutaneously and is connected through a catheter to deliver the drug into desired body part. These pumps are used to deliver anti-spasmodic, chemotherapeutic agents and opioid drugs.

By Pump Type
Perfusion pumps
Micro pumps
By Application
Pain
Spasticity
Cardiovascular
Others
By End users
Hospitals
Ambulatory Surgical Centers
Others
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

In Application Segment, Cardiovascular Segment is Expected to Dominate the Market in the Forecast Period.

In application segment Cardiovascular is expected to dominate the market due to continuous growth of cardiac diseases in the growing population around the world. According to WHO Cardiavascular diseases are main cause of death globally, with an estimated 17.9 million deaths yearly which accounts for 31% of all global deaths. The changing life style in the developing and developed countries is creating health risks majorly related to Cardiovascular disorders. All these factors together supports that Cardiovascular segment dominates the Smart Implantable Pumps market.

 intelligent pumps market share

North America Dominates the Market and the Same is Expected Over the Forecast Period.

North America is expected to dominate the overall market, throughout the forecast period, which is attributed to the developed economy, increasing health care expenditure, increasing incidence of lifestyle-related diseases and the high adoption of technologically advanced products in the region. Furthermore, according to the World Population Prospects: the 2019 Revision, one in four persons living in North America could be aged 65 or over by 2050 which strongly supports the growth of the geriatric population that is more prone to the Cardiovascular risks. Thus, these factors together support that North America dominates the Smart Implantable Pumps market during the forecast period.

smart implantable pumps market growth by region

Competitive Landscape

The Smart Implantable Pumps market is moderately competitive and consists of several major players. With the increasing consolidations of various organizations and product recalls in the healthcare sector, it is expected to generate competitive rivalry among the key players in the future. Some of the major players of the market Medtronic, Tricumed Medizintechnik GmbH, Flowonix Medical, Abbott Laboratories, Berlin Heart, etc.,

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High prevalence and Incidence of Chronic diseases such as Spasticity & Chronic pain

      2. 4.2.2 Growing Geriatric Population

      3. 4.2.3 Growing Healthcare Consciousness, Rising Healthcare Expenditure and Favourable Reimbursement Policies

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Framework

      2. 4.3.2 High-quality Standards set by the Market Leaders

      3. 4.3.3 Pressure on the Companies due Product Recalls

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Pump Type

      1. 5.1.1 Perfusion pumps

      2. 5.1.2 Micro pumps

    2. 5.2 By Application

      1. 5.2.1 Pain

      2. 5.2.2 Spasticity

      3. 5.2.3 Cardiovascular

      4. 5.2.4 Others

    3. 5.3 By End users

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Others

    4. 5.4 By Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Medtronic Plc

      2. 6.1.2 Tricumed Medizintechnik GmbH

      3. 6.1.3 Flowonix Medical Inc

      4. 6.1.4 Abbott Laboratories

      5. 6.1.5 Berlin Heart Inc

      6. 6.1.6 Intercia Therapeutics

      7. 6.1.7 Cognos Therapeutics, Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The undefined market is studied from 2018 - 2026.

The undefined is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Medtronic, Tricumed Medizintechnik GmbH , Flowonix Medical Inc , Abbott, Cognos Therapeutics, Inc. are the major companies operating in undefined.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!